{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:23Z","timestamp":1786993103995,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jocn.2007.04.010","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T08:24:14Z","timestamp":1207211054000},"page":"516-519","source":"Crossref","is-referenced-by-count":68,"title":["Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia"],"prefix":"10.1016","volume":"15","author":[{"given":"J.M.","family":"Gomez-Arguelles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gilo Arrojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Arag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ruiz Huete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Terr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Anciones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2007.04.010_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945\u20131984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jocn.2007.04.010_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410270114","article-title":"Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945\u20131984","volume":"27","author":"Katusic","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2007.04.010_bib3","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","article-title":"Trigeminal neuralgia: pathology and pathogenesis","volume":"124","author":"Love","year":"2001","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.jocn.2007.04.010_bib4","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.59.5_suppl_2.S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","article-title":"Pharmacotherapy of trigeminal neuralgia","volume":"18","author":"Sindrup","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jocn.2007.04.010_bib6","series-title":"Conn\u2019s Current Therapy","first-page":"948","article-title":"Trigeminal neuralgia","author":"Burcheil","year":"1999"},{"key":"10.1016\/j.jocn.2007.04.010_bib7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2007.04.010_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5694\/j.1326-5377.1980.tb131854.x","article-title":"Sodium valproate in trigeminal neuralgia","volume":"2","author":"Peiris","year":"1980","journal-title":"Med J Aust"},{"key":"10.1016\/j.jocn.2007.04.010_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1054\/jpai.2002.122944","article-title":"Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study","volume":"3","author":"Cheshire","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/j.jocn.2007.04.010_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.51.2.611","article-title":"Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients","volume":"51","author":"Khan","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.48.5.1467","article-title":"Gabapentin for idiopathic trigeminal neuralgia: report of two cases","volume":"48","author":"Sist","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s004150070157","article-title":"Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis","volume":"247","author":"Leandri","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2007.04.010_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1212\/WNL.50.4.1192","article-title":"Alternative uses of lamotrigine and gabapentin in the treatment of trigeminal neuralgia","volume":"50","author":"Carrazana","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0304-3959(97)00104-8","article-title":"Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial","volume":"73","author":"Zakrzewska","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jocn.2007.04.010_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s004150050137","article-title":"Lamotrigine control of trigeminal neuralgia: an expanded study","volume":"244","author":"Canavero","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2007.04.010_bib16","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","article-title":"Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia","volume":"48","author":"Lunardi","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/jnnp.59.6.646","article-title":"Lamotrigine control of idiopathic trigeminal neuralgia","volume":"59","author":"Canavero","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2007.04.010_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0885-3924(01)00275-5","article-title":"Topiramate relieves idiopathic and symptomatic trigeminal neuralgia","volume":"21","author":"Solaro","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jocn.2007.04.010_bib19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.55.10.1587","article-title":"Topiramate relieves refractory trigeminal neuralgia in MS patients","volume":"55","author":"Zvartau-Hind","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000116315","article-title":"Trigeminal neuralgia: its treatment with two new carbamazepine analogues","volume":"26","author":"Farago","year":"1987","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2007.04.010_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jnnp.52.4.472","article-title":"Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia","volume":"52","author":"Zakrzewska","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2007.04.010_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(01)00406-7","article-title":"Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia","volume":"95","author":"Zakrzewska","year":"2002","journal-title":"Pain"},{"issue":"Suppl. 3","key":"10.1016\/j.jocn.2007.04.010_bib23","first-page":"131","article-title":"Oxcarbazepine versus carmabazepine in trigeminal neuralgia: a meta-analysis of three double-blind comparative trials","volume":"58","author":"Beydoum","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib24","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/0304-3959(87)91248-6","article-title":"The analgesic effect of carbamazepine in trigeminal neuralgia","volume":"4","author":"Lidstrom","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.jocn.2007.04.010_bib25","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.04.010_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1600-0404.1993.tb04106.x","article-title":"Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment","volume":"87","author":"Friis","year":"1993","journal-title":"Acta Neurol Scand"},{"issue":"Suppl. 5","key":"10.1016\/j.jocn.2007.04.010_bib27","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jocn.2007.04.010_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00003495-199243060-00007","article-title":"Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders","volume":"43","author":"Grant","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.jocn.2007.04.010_bib29","doi-asserted-by":"crossref","first-page":"152S","DOI":"10.1592\/phco.20.12.152S.35254","article-title":"Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials","volume":"20","author":"Beydoun","year":"2000","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807002895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807002895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T14:47:06Z","timestamp":1588517226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586807002895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0967586807002895"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2007.04.010","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}